Avis Pharmalabs Exim Private Limited
About Avis Pharmalabs Exim Private Limited
Data last updated:
Avis Pharmalabs Exim Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 03 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24100RJ2017PTC056962.
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Vijendra Saini and Monika Khurana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 117 – A Padmawati Colony – I Kings Road, Jaipur, Rajasthan, India – 302019.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.33 Lakh, a decline of 44% compared to the previous year. For the same year it recorded a net loss of ₹71,241 (net margin -16.5%) and EBITDA of -₹59,953 (EBITDA margin -13.8%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Avis Pharmalabs Exim Private Limited's registered office is in Jaipur, Rajasthan.
- Registered Address117 – A Padmawati Colony – I Kings Road, Jaipur, Rajasthan, India – 302019
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avis Pharmalabs Exim is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Avis Pharmalabs Exim Private Limited, buy the company report.
Financials of Avis Pharmalabs Exim Private Limited
FY 2025 filings availableAvis Pharmalabs Exim Private Limited reported revenue of ₹4.33 Lakh (down 44% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 44% in the latest year. EBITDA fell 142% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹59,953 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹71,241 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -13.8% | ||||
| Net Profit Margin | -16.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avis Pharmalabs Exim Private Limited, buy the company report.
Board of directors of Avis Pharmalabs Exim Private Limited
Avis Pharmalabs Exim has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijendra Saini Also directs: Make My Book Online Private Limited | Director | 25 Aug 2023 | 3 Years 2 Months | Current |
| Monika Khurana Also directs: Avis Lifecare Private Limited, Avis Biotec Private Limited | Director | 03 Feb 2017 | 9 Years 8 Months | Current |
| Gurinder Singh Khurana Also directs: Avis Lifecare Private Limited, Avis Biotec Private Limited, Avis Biocare Private Limited and 1 more | Director | 03 Feb 2017 | 9 Years 8 Months | Current |
Peer comparison
Avis Pharmalabs Exim Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shankar Namkin Sales Private Limited | ₹4.34 Lakh (FY 2024) | 0.0% | Jaipur, Rajasthan, India | |||
| Yubu Bevtec Private Limited | ₹4.33 Lakh (FY 2021) | -67.0% | Mumbai, Maharashtra, India | |||
| Arym Hi-Tech (OPC) Private Limited | ₹4.33 Lakh (FY 2021) | -33.0% | Ponda, Goa, India | |||
| Tejaswi Automobile Company Private Limited | ₹4.33 Lakh (FY 2018) | -74.0% | Patna, Bihar, India | |||
| Shirsh Life Sciences Private Limited | ₹4.33 Lakh (FY 2024) | 165.0% | Patna, Bihar, India | |||
| Avis Pharmalabs Exim Private Limitedthis company | ₹4.33 Lakh (FY 2024) | -₹71,241 | -16.5% | -44.0% | Jaipur, Rajasthan, India | |
| Tulon Materials Private Limited | ₹4.33 Lakh (FY 2024) | Raigarh, Maharashtra, India | ||||
| Mahajan Creations Private Limited | ₹4.33 Lakh (FY 2024) | -45.0% | Ashiyana, Bihar, India | |||
| RNPC Health Care (OPC) Private Limited | ₹4.33 Lakh (FY 2025) | 76.0% | Agartala, Tripura, India | |||
| Flovr Industries Private Limited | ₹4.33 Lakh (FY 2019) | Chattarpur, Delhi, India | ||||
| Raj's Interiors Construction & Suppliers Private Limited | ₹4.33 Lakh (FY 2024) | -11.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Avis Pharmalabs Exim Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Avis Pharmalabs Exim Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avis Pharmalabs Exim Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Avis Pharmalabs Exim Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Avis Pharmalabs Exim Private Limited has 8 board changes on record since 2017: 3 appointments and 5 cessations. The latest: Vijendra Saini was appointed as Director on 25 Aug 2023.
Frequently asked questions
Avis Pharmalabs Exim is an active private limited company based in Jaipur, Rajasthan, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 03 February 2017 (9+ years old) and is registered under CIN U24100RJ2017PTC056962.
Avis Pharmalabs Exim has 3 current directors:
- Vijendra Saini - Director
- Monika Khurana - Director
- Gurinder Singh Khurana - Director
The latest financial statements of Avis Pharmalabs Exim on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Avis Pharmalabs Exim is U24100RJ2017PTC056962. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avis Pharmalabs Exim was incorporated on 03 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Avis Pharmalabs Exim by revenue are Shankar Namkin Sales Private Limited, Yubu Bevtec Private Limited, Arym Hi-Tech (OPC) Private Limited, Tejaswi Automobile Company Private Limited, Shirsh Life Sciences Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Vijendra Saini was appointed as Director on 25 Aug 2023. Amrit Lal Purohit ceased to be Director on 25 Jul 2023. Anil Choudhary ceased to be Director on 25 Jul 2023. Avis Pharmalabs Exim has 8 board changes on record in total.
The registered office of Avis Pharmalabs Exim is at 117 – A Padmawati Colony – I Kings Road, Jaipur, Rajasthan, India – 302019.
Avis Pharmalabs Exim operates in the chemicals industry, in the manufacturing segment.
The compliance status of Avis Pharmalabs Exim is compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.
Avis Pharmalabs Exim can be reached at its registered office: 117 – A Padmawati Colony – I Kings Road, Jaipur, Rajasthan, India – 302019.